INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 319 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $758,948 | -7.2% | 24,003 | +19.9% | 0.00% | 0.0% |
Q2 2023 | $817,639 | +2.9% | 20,025 | -6.2% | 0.00% | 0.0% |
Q1 2023 | $794,463 | +12.0% | 21,348 | +5.1% | 0.00% | 0.0% |
Q4 2022 | $709,487 | +67.7% | 20,314 | +167.6% | 0.00% | 0.0% |
Q3 2022 | $423,000 | +8.2% | 7,592 | +0.2% | 0.00% | 0.0% |
Q2 2022 | $391,000 | -52.7% | 7,577 | -12.4% | 0.00% | -50.0% |
Q1 2022 | $826,000 | -18.5% | 8,645 | +1.0% | 0.00% | 0.0% |
Q4 2021 | $1,013,000 | -8.0% | 8,557 | +4.4% | 0.00% | 0.0% |
Q3 2021 | $1,101,000 | -35.9% | 8,197 | -22.6% | 0.00% | -50.0% |
Q2 2021 | $1,717,000 | +80.0% | 10,586 | -11.0% | 0.00% | +100.0% |
Q1 2021 | $954,000 | +58.5% | 11,897 | +7.3% | 0.00% | 0.0% |
Q4 2020 | $602,000 | +215.2% | 11,087 | +15.2% | 0.00% | +100.0% |
Q3 2020 | $191,000 | -8.2% | 9,621 | -2.9% | 0.00% | 0.0% |
Q2 2020 | $208,000 | +23.8% | 9,912 | -26.8% | 0.00% | 0.0% |
Q1 2020 | $168,000 | – | 13,539 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |